0001179110-21-008515.txt : 20210901 0001179110-21-008515.hdr.sgml : 20210901 20210901201245 ACCESSION NUMBER: 0001179110-21-008515 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210831 FILED AS OF DATE: 20210901 DATE AS OF CHANGE: 20210901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Appelhans Dannielle CENTRAL INDEX KEY: 0001874962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 211231478 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS, INC. STREET 2: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-08-31 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001874962 Appelhans Dannielle C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY ST., SUITE 300 CAMBRIDGE MA 02139 0 1 0 0 Chief Operating Officer Stock Option (Right to Buy) 21.72 2021-08-31 4 A 0 150000 0 A 2031-08-30 Common Stock 150000 150000 D Restricted Stock Units 2021-08-31 4 A 0 50000 0 A Common Stock 50000 50000 D 25% of this option shall vest on August 9, 2022, then in 12 equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares underlying the restricted stock units will vest in four equal annual installments beginning on August 9, 2022. /s/ Joanne M. Protano, Attorney-in-Fact 2021-09-01